###begin article-title 0
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Optineurin coding variants in Ghanaian patients with primary open-angle glaucoma
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
Coding variants in the optineurin gene (OPTN, GLC1E) have been reported to play a role in primary open-angle glaucoma (POAG) in various populations. This study investigated the role of OPTN sequence variants in patients with POAG in Ghana (West Africa).
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
This is a case-control study of unrelated Ghanaian POAG cases and non-glaucomatous controls. Ascertainment criteria for POAG included the presence of glaucomatous optic nerve neuropathy, associated visual field loss, and elevated intraocular pressure (IOP) in both eyes, all in the absence of secondary causes of glaucoma. Controls had normal optic nerves, visual fields, and IOP. All the coding exons of OPTN were polymerase chain reaction (PCR) amplified and sequenced in all 140 cases and 130 controls using an ABI 3730 DNA analyzer.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
All the coding exons of OPTN were sequenced in 140 POAG patients and 130 controls. Several coding variants were identified including M98K, A134A, V147L, P292P, A301G, S321S, and E322K. Three coding variants (V147L, P292P, and A301G) have not been reported previously. There were no significant differences on the frequencies of all the identified variants between POAG cases and controls in this population.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 175 182 <span type="species:ncbi:9606">persons</span>
This is the first comprehensive study of OPTN in a single West African population. Our results suggest that coding variants in OPTN may not contribute to the risk for POAG in persons of West African descent.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Glaucoma is a group of disorders defined by a characteristic loss of retinal ganglion cells associated with optic nerve degeneration and visual field loss. It is the second leading cause of bilateral blindness worldwide [1]. Primary open-angle glaucoma (POAG, OMIM ) is the most common form of glaucoma in the United States and worldwide, afflicting approximately 67 million individuals in the year 2000 alone [1]. Well recognized risk factors for the development of POAG include elevated intraocular pressure (IOP), positive family history of glaucoma, refractive error, and race; African-Americans have a higher risk of developing POAG [1-3].
###end p 11
###begin p 12
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 478 478 478 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 335 340 <span type="species:ncbi:9606">Human</span>
###xml 738 746 <span type="species:ncbi:9606">patients</span>
There is a strong hereditary component to glaucoma as first-degree relatives of affected individuals have a 7-10 fold higher risk of developing the disease than the general population [4]. Using genetic linkage analysis, at least 14 chromosomal loci for POAG (GLC1A- GLC1N) have been identified in family data sets and are listed by  (Human Genome Organization, Geneva, Switzerland). Disease-associated sequence variants in three genes, myocilin (MYOC, GLC1A), optineurin (OPTN,GLC1E), and WD repeat domain 36 (WDR36, GLC1G), have been described in POAG and other types of glaucoma [5-7]. Disease-associated mutations of myocilin are generally associated with a juvenile or early-adult form of POAG, which account for about 3%-5% of POAG patients.
###end p 12
###begin p 13
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 886 887 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 888 890 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 893 897 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1014 1015 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1084 1088 1076 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1144 1145 1136 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1273 1277 1265 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1409 1411 1397 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1414 1418 1402 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1523 1525 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1526 1528 1514 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1588 1590 1576 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1591 1593 1579 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
The mechanistic role of OPTN in the pathogenesis of glaucoma remains unclear. It is widely expressed in both ocular and non-ocular tissues including but not limited to the heart, brain, placenta, liver, skeletal muscle, kidney, and pancreas. In ocular tissues, it is expressed in the trabecular meshwork, non-pigmented ciliary epithelium, retina, Schlemm's canal, and the aqueous humor [8]. The OPTN protein interacts with different proteins that are involved in apoptosis, inflammation, and vasoconstriction [8,9]. OPTN might play a neuroprotective role by reducing retinal ganglion cell susceptibility to apoptosis [8,9]. Overexpression of OPTN blocks cytochrome c release from the mitochondria and protects the cell from hydrogen peroxide-induced cell death [10]. It was also found that OPTN negatively regulates TNF-alpha induced NF-kappaB activation, leading to reduced apoptosis [9,11]. OPTN was originally identified as a dominant, normal tension glaucoma (NTG) gene in a large study involving 54 families [6]. These sequence variants (E50K, M98K, R545Q, and c691-692insAG) in OPTN were considered disease causing in the original study [6]. The variant, E50K, remains the most consistently found in association studies with normal tension glaucoma. It is found that OPTN E50K increases binding to TANK-binding kinase 1 (TBK1), which forms a complex to regulate TNF-alpha and its pro-apoptotic effects [12]. OPTN sequence variations have also been shown to be associated with POAG in Indian and Japanese populations [13,14] while playing a much less significant role in Caucasians [15-18].
###end p 13
###begin p 14
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
African-American ancestry is estimated to increase the risk of POAG by fourfold to sixfold when compared with European ancestry [19]. African-Americans are largely descended from ancestors in West Africa. We have previously shown that POAG in Ghana has an earlier age of onset and appears to be more clinically severe than in the United States and Europe [20]. POAG patients with mutations in myocilin have a similar phenotype. In an earlier investigation, we reported that myocilin mutations cause approximately 4% of POAG in West Africa [21,22]. This report investigates the role of OPTN coding variants in POAG cases and controls in the same West African population from Ghana.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Subjects
###end title 16
###begin p 17
This study adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all participating individuals after explanation of the nature and possible consequences of the study. The research was reviewed and approved by the institutional review boards of all participating institutions including Duke University Medical Center (Durham, NC) and the Ghana Ministry of Health (Accra, Ghana).
###end p 17
###begin p 18
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1055 1056 1055 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
Clinical data and DNA samples were collected from individuals identified with POAG and unaffected family members from Ghana. All POAG cases and controls were enrolled from either private clinics or the University of Ghana in Accra, the capital of this country. All patients recruited for the study were screened and ascertained by fellowship-trained glaucoma subspecialists (P.C., L.W.H., or R.R.A.). POAG subjects were unrelated and met the following three inclusion criteria: (1) intraocular pressure (IOP; by applanation tonometry) greater than 22 mmHg in both eyes without medications or greater than 19 mmHg on two or more medications; (2) glaucomatous optic neuropathy in both eyes; and (3) visual field loss consistent with optic nerve damage in at least one eye [23]. Glaucomatous optic nerve damage was defined as a vertical cup-to-disc ratio higher than 0.7 or a focal loss of the nerve fiber layer (notch), which is associated with a consistent glaucomatous visual field defect. Visual fields were performed using standard automated perimetry [1]. An open anterior chamber angle has been found in all of our POAG cases. Exclusion criteria included the presence of any secondary form of glaucoma including exfoliation syndrome or a history of ocular trauma. The criteria for unrelated control subjects were (1) no first degree relative with glaucoma; (2) intraocular pressure less than 22 mmHg tested by applanation tonometry on two occasions; (3) no evidence of glaucomatous optic neuropathy; and (4) normal visual field by automated perimetry or frequency doubling test (FDT).
###end p 18
###begin title 19
DNA analysis
###end title 19
###begin p 20
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1062 1065 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
Genomic DNA was extracted from peripheral blood by standard techniques (Gentra, Minneapolis, MN). Primers flanking each coding exon (exon 4-16) in OPTN were designed with  software [24] and were listed in Table 1. All sequencing was performed using appropriately selected primers and conditions optimized in a standard fashion. Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) was used for all the polymerase chain reactions (PCRs). The PCRs were performed in MJ Research PTC-200 PCR machines (MJ Research, Waltham, MA) using a touchdown program (94 degreesC 3 min; then 94 degreesC 30 s, 65 degreesC 30 s, 72 degreesC 30 s for two cycles; 94 degreesC 30 s, 63 degreesC 30 s, 72 degreesC 30 s for two cycles; 94 degreesC 30 s, 61 degreesC 30 s, 72 degreesC 30 s for two cycles; 94 degreesC 30 s, 59 degreesC 30 s, 72 degreesC 30 s for two cycles; 94 degreesC 30 s, 57 degreesC 30 s, 72 degreesC 30 s for two cycles; 94 degreesC 30 s, 55 degreesC 30 s, 72 degreesC 30 s for 30 cycles; and 72 degreesC 3 min). Sequencing reactions were performed using BigDye(R) Terminator v3.1 Cycle Sequencing Kits (Applied Biosystems, Foster City, CA) and run on the ABI 3730 DNA analyzer (Applied Biosystems). All the sequence analysis was done by using the Sequencher 4.8 (Gene Codes, Ann Arbor, MI). All suspected variations were confirmed by bidirectional sequencing. The M98K variant was subsequently genotyped using a custom TaqMan SNP (single nucleotide polymorphism) Genotyping Assay (Applied Biosystems). The E322K variant could not be genotyped by TaqMan SNP genotyping due to the lack of available assay from ABI (Applied Biosystems).
###end p 20
###begin title 21
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
List of PCR primers for OPTN DNA sequencing in Ghanaian POAG cases and controls.
###end title 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
Sequencing data were analyzed as mentioned previously [25,26]. Briefly, allele frequencies for each coding variant in POAG cases and controls were compared by logistic regression with adjustment for age and sex (SAS software; SAS Institute Inc., Cary, NC). Analysis of the Hardy-Weinberg equilibrium (HWE) was performed separately for patients and controls using  (Genetic Data Analysis) software according to previously described methods [25]. SNP genotypes were coded according to a log-additive model in which the relative risk for carriers of two variant (minor) alleles when compared with the reference group (homozygous wild-type) was assumed to be the square of the relative risk for carriers of one variant. A p value less than 0.05 was considered statistically significant.
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
DNA and relevant clinical data were collected from 140 POAG cases and 130 controls. Detailed information about this data set has been described previously [25,26]. Briefly, the mean ages for POAG cases and controls were 63+/-12.6 years old and 59.4+/-12.6 years old, respectively. The percentages of POAG cases and controls that were female were 50% and 57%, respectively. The mean IOPs for POAG cases and controls were 33.6+/-11.1 mmHg and 17.2+/-2.8 mmHg, respectively.
###end p 25
###begin p 26
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 191 198 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1040 1047 1040 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 1530 1534 1530 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 668 675 <span type="species:ncbi:9606">patient</span>
###xml 707 714 <span type="species:ncbi:9606">patient</span>
###xml 1061 1069 <span type="species:ncbi:9606">patients</span>
###xml 1145 1153 <span type="species:ncbi:9606">patients</span>
Seven coding variants were identified in OPTN in this data set. There were three synonymous (A134A, P292P, and S321S) and four non-synonymous (M98K, V147L, A301G, and E322K) coding variants (Table 2). The M98K, A134A, S321S, and E322K variants have been reported in other populations [6,15,16,27-30]. The other three coding variants (V147L, P292P, and A301G) are novel and have not been previously reported. The M98K variant in exon 5 was detected in 43 cases (two homozygotes and 41 heterozygotes) and 33 controls (two homozygotes and 31 heterozygotes; p>0.05). One individual with POAG had a novel V147L variation in exon 6 as a heterozygote. The age-onset for this patient was 59 years old. Another POAG patient whose age-onset was relative early at the age of 40 years had a novel A301G variant in exon 10 as a heterozygote. None of the controls exhibited either of these two sequence variants. However, neither of these variants showed any statistically significant difference in allele frequencies between cases and controls (p>0.05; Table 3). Seven POAG patients and one control had the heterozygous E322K variant in exon 10. These seven patients have relatively high IOP (>30 mmHg). However, the allele frequency of this variant is not significantly different between POAG cases and controls (p>0.05). None of the remaining synonymous coding variants (A134A, P292P, and S321S) showed significantly different allele frequencies between POAG cases and controls. No HWE problem was detected for any of the coding variants in OPTN (p>0.05).
###end p 26
###begin title 27
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
OPTN DNA sequence variants in Ghana POAG patients.
###end title 27
###begin p 28
Nucleotides are numbered as in GenBank .
###end p 28
###begin title 29
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Allele frequencies of sequencing variants in OPTN in POAG patients and control subjects.
###end title 29
###begin p 30
The asterisk denotes that the p value is from logistic regression with the adjustment for age and sex. POAG: primary open-angle glaucoma.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
In this study, we report the contribution of OPTN variants in POAG cases in Ghana. We found a total of seven OPTN coding variants, four of which were non-synonymous and three were synonymous coding variants. Of these variants, three have not been previously reported. The large number of novel OPTN variants is likely due to two factors. First, our study is the first comprehensive study to examine the sequencing variants of OPTN in a single western African population. Second, African populations may have greater genetic diversity compared with the non-African populations reported to date [31,32]. The African populations arise from ancient and recent population expansion and contraction, short and long range migrations, and population admixture.
###end p 32
###begin p 33
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
The genetic association between OPTN variants and glaucoma has been extensively studied in different populations. Mutations in OPTN account for about 16% of familial POAG with normal tension in the original study [33]. These sequence variants (M98K, E50K, R545Q, and c691-692insAG) were considered disease-causing originally [6]. E50K has been consistently confirmed by many studies as disease-causing [8,9,33]. R545Q has not been confirmed in other populations [9,33]. Other variants have also been reported in POAG patients including T34T, E163E, 553-5C, and E322K [9,28,34].
###end p 33
###begin p 34
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 980 984 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 673 681 <span type="species:ncbi:9606">patients</span>
###xml 803 811 <span type="species:ncbi:9606">patients</span>
Coding variant, E322K (), was found to be present in more POAG cases than controls, although it failed to show any statistical significance. Interestingly, this SNP has been shown to have a minor allele (A) frequency of 0.05, which is unique and found only in sub-Saharan African  samples. It is not polymorphic in either Caucasian or Asian (Chinese or Japanese)  samples. Ayala-Lugo and colleagues [28] also identified this variant in samples of African ancestry including African American, Ghanaian, Nigerian, and the Caribbean. They did not find any significant difference in allele frequency between cases of open-angle glaucoma and controls with the sample size of 81 patients and 88 controls. Our study has a much larger data set of 140 POAG cases and 130 controls, all from Accra, Ghana. All the patients with E322K variants have relative high IOP (>30 mmHg) and the age-onset ranges from 43 to 85 years old. Both Ayala-Lugo's and our studies suggest that E322K variant in OPTN may not contribute to the increased risk of POAG in the population of African ancestry.
###end p 34
###begin p 35
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
The M98K OPTN variant is the most common variant reported in most studies [13,33]. Similar to others, we have found that the M98K variant is the most prevalent in this population. The M98K variant was originally described as a risk-associated alteration for hereditary adult-onset POAG [6]. This variant has been reported to be a potential risk factor for NTG or POAG in some Asian populations [6,14,15,27,34-36]. However, most studies have not found an association between this variant and either NTG or POAG [16-18,37-42]. Consistent with these studies, we also failed to identify an association of the M98K variant with POAG in the Ghanaian population.
###end p 35
###begin p 36
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 571 575 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
###xml 610 618 <span type="species:ncbi:9606">patients</span>
Both V147L and A301G variants are novel. Each of them was found in a single POAG case and none of the controls. The age-onset for both patients is relatively early (40 and 59 years old). The IOP for these two patients is also relatively high, more than 30 mmHg. Although not statistically significant, it remains possible that these rare variants might contribute to the pathogenesis of POAG. Additional studies in larger data sets will be necessary to corroborate the role of these OPTN variants in glaucoma. Although we did not find any significant association between OPTN coding variants and Ghanaian POAG patients with elevated IOP, it is important to check these variants, especially the novel ones, in other populations with a large data set and to check their functional impact with the OPTN protein.
###end p 36
###begin p 37
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 177 185 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
In conclusion, we have identified seven genetic variants of OPTN of which three are novel in the Ghanaian population. Two non-synonymous coding variants were found only in POAG patients and not in controls. The study presented here is the first large scale comprehensive analysis of OPTN variants in the Ghanaian (West African) POAG patients with elevated intraocular pressure.
###end p 37
###begin title 38
Acknowledgments
###end title 38
###begin p 39
###xml 32 44 <span type="species:ncbi:9606">participants</span>
###xml 88 93 <span type="species:ncbi:9606">Human</span>
###xml 280 288 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
The authors thank all the study participants and the study staff at the Duke Center for Human Genetics and the Department of Ophthalmology at Duke University Eye Center for their assistance. The authors also thank Alice Ventura and Melanie Jones for their assistance in enrolling patients and Brian Welcome for his assistance in recruiting patients for the study. This work was supported by NIH grants, R01EY013315 (M.A.H.), R03EY014939 (R.R.A.), R01EY015543 (R.R.A), and NIH K23 EY014019 (P.C.) as well as the Glaucoma Research Foundation, the American Health Assistance Foundation, and Research to Prevent Blindness.
###end p 39
###begin title 40
References
###end title 40
###begin article-title 41
###xml 14 21 <span type="species:ncbi:9606">persons</span>
The number of persons with glaucoma worldwide in 2010 and 2020.
###end article-title 41
###begin article-title 42
Race, ethnicity and prevalence of primary open-angle glaucoma.
###end article-title 42
###begin article-title 43
Genetic etiologies of glaucoma.
###end article-title 43
###begin article-title 44
Multivariate analysis in glaucoma. Use of discriminant analysis in predicting glaucomatous visual field damage.
###end article-title 44
###begin article-title 45
###xml 18 23 <span type="species:ncbi:9606">Child</span>
heon E, Crick RP, Child A, Sarfarazi M. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 45
###begin article-title 46
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 46
###begin article-title 47
Identification of a gene that causes primary open angle glaucoma.
###end article-title 47
###begin article-title 48
Optineurin in primary open angle glaucoma.
###end article-title 48
###begin article-title 49
The genetics of primary open-angle glaucoma: A review.Exp Eye Res, in press.
###end article-title 49
###begin article-title 50
Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus.
###end article-title 50
###begin article-title 51
Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.
###end article-title 51
###begin article-title 52
Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma.
###end article-title 52
###begin article-title 53
Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population.
###end article-title 53
###begin article-title 54
###xml 22 30 <span type="species:ncbi:9606">patients</span>
OPTN gene: profile of patients with glaucoma from India.
###end article-title 54
###begin article-title 55
Complex genetics of glaucoma susceptibility.
###end article-title 55
###begin article-title 56
Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study.
###end article-title 56
###begin article-title 57
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States.
###end article-title 57
###begin article-title 58
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma.
###end article-title 58
###begin article-title 59
Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.
###end article-title 59
###begin article-title 60
Survey of glaucoma in an eye clinic in Ghana, West Africa.
###end article-title 60
###begin article-title 61
Prevalence of myocilin mutations in adults with primary open-angle glaucoma in Ghana, West Africa.
###end article-title 61
###begin article-title 62
Glaucoma in Ghana, West Africa: clinical features and the role of mutations in Myocilin.
###end article-title 62
###begin article-title 63
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma.
###end article-title 63
###begin article-title 64
Primer3 on the WWW for general users and for biologist programmers.
###end article-title 64
###begin article-title 65
No association between OPA1 polymorphisms and primary open-angle glaucoma in three different populations.
###end article-title 65
###begin article-title 66
Lack of Association between LOXL1 variants and Primary Open-angle Glaucoma in Three Different Populations.
###end article-title 66
###begin article-title 67
Prevalence of optineurin sequence variants in adult primary open angle glaucoma: implications for diagnostic testing.
###end article-title 67
###begin article-title 68
Variation in optineurin (OPTN) allele frequencies between and within populations.
###end article-title 68
###begin article-title 69
###xml 88 96 <span type="species:ncbi:9606">patients</span>
The M98K variant of the OPTINEURIN (OPTN) gene modifies initial intraocular pressure in patients with primary open angle glaucoma.
###end article-title 69
###begin article-title 70
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients.
###end article-title 70
###begin article-title 71
###xml 44 49 <span type="species:ncbi:9606">Human</span>
###xml 78 83 <span type="species:ncbi:9606">Human</span>
African Genetic Diversity: Implications for Human Demographic History, Modern Human Origins, and Complex Disease Mapping.
###end article-title 71
###begin article-title 72
Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.
###end article-title 72
###begin article-title 73
Complex genetics of complex traits: the case of primary open-angle glaucoma.
###end article-title 73
###begin article-title 74
The role of the Met98Lys optineurin variant in inherited optic nerve diseases.
###end article-title 74
###begin article-title 75
Mutations and polymorphisms in the genes for myocilin and optineur in as the risk factors of primary open-angle glaucoma.
###end article-title 75
###begin article-title 76
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Clinical relevance of optineurin sequence alterations in Japanese glaucoma patients.
###end article-title 76
###begin article-title 77
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
###end article-title 77
###begin article-title 78
Optineurin gene is not involved in the common high-tension form of primary open-angle glaucoma.
###end article-title 78
###begin article-title 79
The role of TIGR and OPTN in Finnish glaucoma families: a clinical and molecular genetic study.
###end article-title 79
###begin article-title 80
Analysis of rare variants and common haplotypes in the optineurin gene in Swedish glaucoma cases.
###end article-title 80
###begin article-title 81
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Role of MYOC and OPTN sequence variations in Spanish patients with primary open-angle glaucoma.
###end article-title 81
###begin article-title 82
Absence of myocilin and optineurin mutations in a large Philippine family with juvenile onset primary open angle glaucoma.
###end article-title 82

